In Trading, Results Matter.
Our Top 10 exits in last 5 trading days.

Clearside Biomedical Inc. Trade Record

NASDAQ:CLSD Clearside Biomedical Inc stock gains 10.58% Exit Feb 19, 2019 a Trade Record by priceseries

Trade Chart
Trade Chart CLSD Jan 30, 2019, priceSeries
About Clearside Biomedical Inc

Clearside BioMedical, Inc., a biopharmaceutical company, develops drug therapies to treat chronic blinding diseases of the eye. Its products include CLS-1001 for the treatment of macular edema associated with non-infectious uveitis; CLS-1003 for the treatment of macular edema associated with retinal vein occlusion; and CLS-1002 program for the treatment of wet age-related macular degeneration. The company was founded in 2011 and is headquartered in Alpharetta, Georgia.

Trade Information
Trade Type
Entry Date
Jan 30, 2019
Entry Price
Sell Date
Feb 19, 2019
Sell Price
Net Gain
Hold Time
13 Trading Days